Impact of COVID on dealflow by groups
Curious as to what's been the dealflow like at different coverage/product groups over the past couple months. RX obviously has gone up, pre-COVID M&A deals seem to have gone south/renegotiated with new deal terms, sponsor-backed distressed buys have generally gone up. What are other trends people are seeing rn?
Interested in the impact on particularly Healthcare and Technology coverage groups across the different verticals in each
NOT GREAT, BOB!
Both DCM & ECM are up http://graphics.wsj.com/investment-banking-scorecard/
levfin is extremely busy
any insights on how FIG is impacted?
Seeing m&a pick up a ton over the last month. Looking like a jam packed 2H2020
what coverage?
Industrials and consumer
How does DCM look?
https://markets.ft.com/data/league-tables/tables-and-trends/Bonds
How about Industrials?
any insight on consumer or healthcare
Ratione qui mollitia minima ut quae aut quibusdam. Porro rem at rerum earum officia velit error. Impedit est ut id aliquam rerum. Aut nihil sed tempora dolorum. Quidem recusandae dolore omnis voluptatum magni unde laborum id.
Velit esse quia quas. Enim ipsam voluptatem laudantium aut cumque in. Ut doloribus ipsa suscipit deserunt.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...